MCM
GHDX

Manchester Capital Management’s Genomic Health, Inc. GHDX Stock Holding History

Manchester Capital Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-793
Closed -$56K – 680
2019
Q1 		$56K Buy
+793
New +$58.8K 0.01% 391

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Manchester Capital Management's GHDX Position: Q2 2019 in Review

Manchester Capital Management sold out of Genomic Health, Inc. (GHDX) in Q2 2019, closing a stake of 793 shares — an estimated $56K sold.

Manchester Capital Management first reported a position in GHDX in Q1 2019 and held it in 1 quarter. The position peaked at $56K in Q1 2019. 215 funds tracked by Wall St. Rank hold GHDX as of Q2 2019.

  • Manchester Capital Management reported no remaining Genomic Health, Inc. position as of Q2 2019 after selling out during the quarter.
  • Manchester Capital Management sold 793 Genomic Health, Inc. shares in Q2 2019, an estimated $56K.
  • Manchester Capital Management first reported a position in Genomic Health, Inc. in Q1 2019 and held it in 1 quarter.
  • Manchester Capital Management's Genomic Health, Inc. position peaked at $56K in Q1 2019.
  • 215 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2019.

Based on Manchester Capital Management's 13F filing for Q2 2019, filed 5 Aug 2019.